- Trials with a EudraCT protocol (45)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
45 result(s) found for: Asthenia.
Displaying page 1 of 3.
EudraCT Number: 2010-020504-30 | Sponsor Protocol Number: Gatac | Start Date*: 2010-06-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: GATAC: Asian ginseng (Panax Ginseng) for the treatment of Cancer-Related Fatigue: a randomized, double-blind controlled study. | |||||||||||||
Medical condition: Cancer-related fatigue (CRF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002171-27 | Sponsor Protocol Number: METILÁS09/2008 | Start Date*: 2008-08-27 | |||||||||||
Sponsor Name:Instituto Científico y Tecnológico de Navarra, SA. (ICT). | |||||||||||||
Full Title: ENSAYO CLÍNICO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y MULTICÉNTRICO PARA EVALUAR LA EFICACIA DEL TRATAMIENTO PALIATIVO CON METILFENIDATO EN ASTENIA (DE PACIENTES CON CÁNCER AVANZADO). | |||||||||||||
Medical condition: Astenia en pacientes con cáncer avanzado. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022114-12 | Sponsor Protocol Number: MW012 | Start Date*: 2010-12-20 |
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | ||
Full Title: Multizentrische prospektive randomisierte kontrollierte offene Phase IV Studie zur Evaluation von Synergien zwischen WS® 1070 und strukturiertem Stressmanagement bei Patienten mit nachlassender Lei... | ||
Medical condition: Asthenia and decreased concentration capacity as well as fatigue and feeling of weakness along with subjective stress | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004231-37 | Sponsor Protocol Number: 1368-0013 | Start Date*: 2019-01-22 | |||||||||||
Sponsor Name:Boehringer Ingelheim France | |||||||||||||
Full Title: Multi-center, double-blind, randomised, placebo-controlled, Phase II study to evaluate efficacy, safety and tolerability of BI 655130 in patients with Generalized Pustular Psoriasis (GPP) presentin... | |||||||||||||
Medical condition: Generalized Pustular Psoriasis (GPP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004639-24 | Sponsor Protocol Number: STUDIO L-ARGININA | Start Date*: 2005-10-24 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome. | |||||||||||||
Medical condition: metabolic syndrome treatment for diabet type II prevention | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000972-25 | Sponsor Protocol Number: AB06006 | Start Date*: 2013-06-06 | |||||||||||
Sponsor Name:AB SCIENCE | |||||||||||||
Full Title: A 24-week with possible extension, prospective, multicentre, randomized, double blind, placebo-controlled, 2-parallel group with a randomization 1:1, Phase III study to compare efficacy and safety ... | |||||||||||||
Medical condition: Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis with handicaps | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) CZ (Completed) SK (Completed) LV (Completed) AT (Completed) DE (Prohibited by CA) GB (Completed) IT (Completed) BG (Completed) HU (Completed) GR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003824-36 | Sponsor Protocol Number: SATEME-08 | Start Date*: 2005-09-15 |
Sponsor Name:Fundació Institut Català de Farmacologia | ||
Full Title: Randomized, double blind, parallel groups, placebo controlled pivotal clinical trial to asses preliminary efficacy and security of a sublingual Cannabis Standardized Extract (Sativex) added to refe... | ||
Medical condition: Chemotherapy induced nausea and vomiting | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006069-39 | Sponsor Protocol Number: LPS16141 | Start Date*: 2022-06-26 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A Randomized, Double-Blind, Parallel-Group Clinical Trial to Assess the Efficacy of Essentiale on Hepatic Steatosis Added to Standard of Care Versus Placebo Added to Standard of Care, in Non-Alcoho... | |||||||||||||
Medical condition: Non-alcoholic fatty liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000605-24 | Sponsor Protocol Number: ESPERANZA_COVID | Start Date*: 2021-07-08 | |||||||||||
Sponsor Name:IDIAP Jordi Gol | |||||||||||||
Full Title: Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID: E-SPERANZA COVID PROJECT | |||||||||||||
Medical condition: Patients with a history of SAR-Cov-2 infection (PCR positive) with long Covid-19 and mild or moderate respiratory symptoms of more than 1 month and less than 4 months of evolution, attended in Prim... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001131-61 | Sponsor Protocol Number: no sponsor | Start Date*: 2007-06-20 | |||||||||||
Sponsor Name:Belgian Group of Digestive Oncology | |||||||||||||
Full Title: A national randomised multi-centre trial to assess the effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcino... | |||||||||||||
Medical condition: To evaluate the effect and tolerability of high dose Mg gluconate oral substitution in the (1) prevention and (2) treatment of magnesium wasting due to anti-EGFR treatment in colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004600-19 | Sponsor Protocol Number: PAINTER01 | Start Date*: 2014-01-21 |
Sponsor Name:Azienda Ospedaliera Fatebenefratelli e Oftalmico - Milano, Italy | ||
Full Title: Multicenter, interventional, single-arm, phase IV study evaluating tolerability of Eribulin and its relationship with a set of polymorphisms in an unselected population of female patients with meta... | ||
Medical condition: Patients with metastatic breast cancer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001385-11 | Sponsor Protocol Number: PrEP_COVID_19 | Start Date*: 2020-03-28 | |||||||||||
Sponsor Name:Plan Nacional Sobre SIDA | |||||||||||||
Full Title: Prevention of SARS-CoV-2 (COVID-19) through Pre-Exposure Prophylaxis with Tenofovir disoproxil/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial controlled wit... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002123-11 | Sponsor Protocol Number: HUIS-04-2020 | Start Date*: 2020-05-07 | |||||||||||
Sponsor Name:Tatiana Cobo Ibáñez [...] | |||||||||||||
Full Title: EFFICACY OF CYCLOSPORINE IN THE TREATMENT OF COVID-19 PNEUMONIA: A RANDOMIZED CONTROLLED TRIAL. | |||||||||||||
Medical condition: COVID-19 PNEUMONIA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002029-28 | Sponsor Protocol Number: RC20_0191 | Start Date*: 2021-02-05 | |||||||||||
Sponsor Name:CHU Nantes | |||||||||||||
Full Title: Doxycycline Versus Placebo in COVID-19 + Patients without hospitalization criteria: Prospective, multicenter, randomized, double-blind, prospective study. | |||||||||||||
Medical condition: COVID-19 disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002190-37 | Sponsor Protocol Number: P140302 | Start Date*: 2015-10-30 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in patients with Behçet disease : STELABEC | |||||||||||||
Medical condition: Behçet disease STELABEC-1: patients with oral ulcers STELABEC-2 : patients with active posterior uveitis or panuveitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001641-89 | Sponsor Protocol Number: PM1183-C-003-14 | Start Date*: 2016-06-28 | |||||||||||
Sponsor Name:Pharma Mar S.A. | |||||||||||||
Full Title: Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients w... | |||||||||||||
Medical condition: Small-Cell Lung Cancer (SCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) BE (Completed) ES (Completed) DE (Completed) GR (Completed) PT (Completed) CZ (Completed) NL (Completed) BG (Completed) GB (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004259-40 | Sponsor Protocol Number: 0974-012-07 | Start Date*: 2007-04-27 | |||||||||||
Sponsor Name:Merck & Co Inc., | |||||||||||||
Full Title: A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura | |||||||||||||
Medical condition: Migraine | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) AT (Completed) FR (Completed) IT (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000085-42 | Sponsor Protocol Number: LLB-2019-03 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:LABO'LIFE Belgium sprl | ||||||||||||||||||||||||||||
Full Title: Randomized, placebo-controlled, double blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection. EBVAST Study | ||||||||||||||||||||||||||||
Medical condition: Epstein-Barr Virus infection | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000434-21 | Sponsor Protocol Number: PRT-PEG-15-10880 | Start Date*: 2016-11-14 | |||||||||||
Sponsor Name:Biogen Portugal | |||||||||||||
Full Title: PLENO – Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients with Relapsing Remitting Multiple Sclerosis (MS) Transitioning from Current... | |||||||||||||
Medical condition: Relapsing-remitting multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003135-36 | Sponsor Protocol Number: CYD67 | Start Date*: 2019-10-31 |
Sponsor Name:Sanofi Pasteur SA | ||
Full Title: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially with Gardasil® in Healthy Subjects Aged 9 to 13 Years in Malaysia | ||
Medical condition: Dengue Fever Dengue Hemorrhagic Fever Human Papillomavirus Disease | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.